Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome

doi:10.4252/wjsc.v5.i1.9

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5247)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-9) series.

Item

Count

PDF

400

HTML

4331

Figures (1-8)

266

Tables (1-9)

250

Sum=5247

Jan 26, 2013 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Stem Cells. Jan 26, 2013; 5(1): 9-25
Published online Jan 26, 2013. doi: 10.4252/wjsc.v5.i1.9

Table 3 Proteins which are upregulated upon ciclopirox olamine treatment compared to control

	k/CPX
	ESC	maGSC
Actb	0.13	0.19
Atp5a1¹	0.41	0.54
Ctsd	0.97	0.09
Eif3f¹	0.94	0.43
Eif3i¹	0.49	0.95
Etfa	0.63	0.39
Hspa9	0.92	0.31
Hspb1	0.63	0.05
Hspd1	0.19	0.21
Hspd1	0.36	0.69
Myh9¹	0.63	0.09
Nup62¹	0.30	0.60
S100a11		0.21
Tubb2a	1.00	0.21
Vdac1	0.58	0.18

¹The proteins are referred to in the text and following tables. CPX: Ciclopirox olamine; ESC: Embryonic stem cell; maGSC: Multipotent adult germline stem cell.

Citation: Dihazi GH, Bibi A, Jahn O, Nolte J, Mueller GA, Engel W, Dihazi H. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. World J Stem Cells 2013; 5(1): 9-25
URL: https://www.wjgnet.com/1948-0210/full/v5/i1/9.htm
DOI: https://dx.doi.org/10.4252/wjsc.v5.i1.9